The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line.
 
Andrea Pretta
No Relationships to Disclose
 
Clelia Donisi
No Relationships to Disclose
 
Riccardo Giampieri
No Relationships to Disclose
 
Pina Ziranu
No Relationships to Disclose
 
Erika Cimbro
No Relationships to Disclose
 
Dario Spanu
No Relationships to Disclose
 
Federica Pecci
No Relationships to Disclose
 
Marco Migliari
No Relationships to Disclose
 
Francesca Balconi
No Relationships to Disclose
 
Alessio Lupi
No Relationships to Disclose
 
Enrico Palmas
No Relationships to Disclose
 
Giulia Deias
No Relationships to Disclose
 
Benedetta Congiu
No Relationships to Disclose
 
Marta Pozzari
No Relationships to Disclose
 
Sara Murgia
No Relationships to Disclose
 
Pusceddu Valeria
No Relationships to Disclose
 
Marco Puzzoni
No Relationships to Disclose
 
Eleonora Lai
Consulting or Advisory Role - AstraZeneca; MSD
 
Rossana Berardi
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Boehringer Ingelheim; Eisai; GlaxoSmithKline; Lilly; MSD Oncology (Inst); Novartis (Inst); Otsuka; Roche (Inst)
 
Mario Scartozzi
Consulting or Advisory Role - Amgen; Bayer; Eisai; Merck; MSD; Sanofi
Speakers' Bureau - Amgen; Bayer; Eisai; Merck; MSD; Sanofi